5716 DAN 150 Pill - orange round
Pill with imprint 5716 DAN 150 is Orange, Round and has been identified as Amoxapine 150 mg. It is supplied by Watson Pharmaceuticals.
Amoxapine is used in the treatment of Depression and belongs to the drug class tricyclic antidepressants. Risk cannot be ruled out during pregnancy. Amoxapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 5716 DAN 150

Amoxapine
- Imprint
- 5716 DAN 150
- Strength
- 150 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Tricyclic antidepressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00364-2435 (Discontinued)
See also:
Lexapro
Lexapro is used to treat anxiety and major depressive disorder. Learn about side effects ...
Zoloft
Zoloft is an antidepressant used to treat major depression, obsessive-compulsive disorder, panic ...
Rexulti
Rexulti (brexpiprazole) is a prescription antipsychotic medication used in the treatment of major ...
Abilify
Abilify is an antipsychotic medicine used to treat the symptoms of schizophrenia and bipolar ...
Seroquel
Seroquel is used to treat the symptoms of schizophrenia, bipolar disorder and major depressive ...
Prozac
Prozac (fluoxetine) is an SSRI antidepressant used to treat depression, OCD, panic disorder ...
Cymbalta
Cymbalta (duloxetine) is used to treat major depressive disorder, general anxiety disorder and ...
Wellbutrin
Wellbutrin (bupropion) is used to treat major depressive disorder and seasonal affective disorder ...
Zyprexa
Zyprexa (olanzapine) is an atypical antipsychotic that may be used to treat adults and adolescents ...
More about amoxapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tricyclic antidepressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.